Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Ketamine petition receives over 3,000 signatures
Stray dog
Ketamine is critical for control of zoonotic diseases like rabies.
Proposal to reschedule drug to be considered this week 

A WSAVA petition calling for ketamine not to be placed under international control has received over 3,000 signatures.

In 2014, China proposed to reclassify the drug to Schedule 1 following widespread misconception that it is only a ‘recreational drug’.

Yet a review by the World Health Organisation (WHO) concluded that ketamine abuse does not pose a global public health threat, and that such control would limit access to those who most need it as a life-saving anaesthetic.

This week, delegates at the 29th UN Convention on Narcotic Drugs (CND) (14-22 March, Vienna) will meet to decide between the two opposite proposals.

In an open letter, the WSAVA urge the CND to follow the recommendations of the WHO. In it they write:

“The proposal for international control stems from the widespread misconception that it is only a 'recreational drug.' This is an inaccurate view and devalues the contribution that ketamine makes to to human and animal health. The WSAVA believes that it is an essential medicine.

“Ketamine is a remarkably safe anaesthetic which has been used worldwide for more than 50 years. It does not depress respiration or the circulation.  It can be used without oxygen, ventilators and electricity supply and support systems required for other anaesthetics.  

“These characteristics make it the only anaesthetic suitable for both medical and veterinary use in lower and middle income countries.”

As well as having particular value ‘in the field’ - for trauma, traffic and sporting injuries, ketamine is the most common and often only product for steralization initiatives. It also plays a huge role in feral cat/dog populations and is critical for control of zoonotic diseases like rabies.

The WSAVA conclude: “The WSAVA believes that medical and veterinary professionals should continue to have access to ketamine under the current scheduling controls and calls on concerned individuals to support our campaign to allow access to this essential medicine.”

To support the campaign and sign the petition visit: www.change.org.

Become a member or log in to add this story to your CPD history

FIVP publishes CMA Compliance Checklist

News Story 1
 FIVP has published a CMA Compliance Checklist to support independent practices with the Market Investigation Order.

The document includes deadlines for small and large businesses, with tick boxes for each of the tasks. The organisation also invites practices to contact them for support with requirements.

Rita Dingwall, FIVP chair, said: FIVP appreciates that navigating the new CMA requirements can feel daunting. We hope this checklist will make things a little easier, helping independent practices work through what is required with confidence. 

Click here for more...
News Shorts
APHA launches free virtual work experience programme

The Animal and Plant Health Agency (APHA), in collaboration with Springpod, has launched a free virtual work experience programme, giving young people across the UK the chance to explore careers dedicated to protecting animal and plant health.

The on-demand programme offers a unique insight into career opportunities within APHA, showcasing how students can contribute to tackling some of the UK's most critical biosecurity and environmental challenges.

Designed for students aged 13 and over, the course includes more than 10 hours of engaging content featuring real-life industry insights, scenario-based challenges, and practical guidance on applying for jobs. To register for the course, visit the APHA website.